| Primary |
| Hypercholesterolaemia |
20.9% |
| Hypertension |
13.9% |
| Hyperlipidaemia |
12.3% |
| Dyslipidaemia |
8.6% |
| Pruritus |
5.3% |
| Blood Cholesterol Increased |
4.8% |
| Coronary Artery Disease |
4.3% |
| Diabetes Mellitus |
4.3% |
| Cerebrovascular Spasm |
3.2% |
| Osteoporosis Postmenopausal |
3.2% |
| Type 2 Diabetes Mellitus |
2.7% |
| Abdominal Pain Upper |
2.1% |
| Cardiovascular Disorder |
2.1% |
| Lipids Abnormal |
2.1% |
| Myalgia |
2.1% |
| Heart Transplant |
1.6% |
| Hepatitis C |
1.6% |
| Nasopharyngitis |
1.6% |
| Rash |
1.6% |
| Renal Failure |
1.6% |
|
| Myalgia |
24.7% |
| Rhabdomyolysis |
9.9% |
| Liver Disorder |
8.6% |
| Vomiting |
7.4% |
| Rash |
6.2% |
| Cardiac Arrest |
3.7% |
| Oesophageal Hypomotility |
3.7% |
| Thrombotic Thrombocytopenic Purpura |
3.7% |
| Uveitis |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Blood Creatine Phosphokinase Increased |
2.5% |
| Cardiac Failure |
2.5% |
| Cerebellar Haematoma |
2.5% |
| Muscle Spasms |
2.5% |
| Musculoskeletal Stiffness |
2.5% |
| Neutrophil Count Decreased |
2.5% |
| Oedema |
2.5% |
| Pain In Extremity |
2.5% |
| Photocoagulation |
2.5% |
| Pyrexia |
2.5% |
|
| Secondary |
| Hyperlipidaemia |
17.7% |
| Product Used For Unknown Indication |
15.1% |
| Hypertension |
12.8% |
| Hypercholesterolaemia |
10.0% |
| Drug Use For Unknown Indication |
9.4% |
| Type 2 Diabetes Mellitus |
5.3% |
| Prophylaxis |
4.0% |
| Glomerulonephritis |
3.7% |
| Blood Cholesterol Increased |
2.9% |
| Type Iib Hyperlipidaemia |
2.6% |
| Diabetes Mellitus |
2.2% |
| Dyslipidaemia |
2.1% |
| Immune Thrombocytopenic Purpura |
2.1% |
| Thrombotic Cerebral Infarction |
2.0% |
| Bipolar Disorder |
1.6% |
| Type Iia Hyperlipidaemia |
1.6% |
| Nephrotic Syndrome |
1.3% |
| Osteoarthritis |
1.3% |
| Coronary Artery Disease |
1.2% |
| Osteoporosis Prophylaxis |
1.1% |
|
| Vomiting |
18.1% |
| Amyotrophic Lateral Sclerosis |
13.0% |
| Rash |
10.9% |
| Pyrexia |
6.5% |
| Talipes |
6.5% |
| Rhabdomyolysis |
5.8% |
| Musculoskeletal Discomfort |
4.3% |
| Myalgia |
4.3% |
| Vision Blurred |
4.3% |
| Myopathy |
2.9% |
| Transaminases Increased |
2.9% |
| Vascular Graft |
2.9% |
| Completed Suicide |
2.2% |
| Drug Tolerance |
2.2% |
| Hepatic Function Abnormal |
2.2% |
| Hepatocellular Injury |
2.2% |
| Interstitial Lung Disease |
2.2% |
| Lung Disorder |
2.2% |
| Nephropathy Toxic |
2.2% |
| Polyneuropathy |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.0% |
| Hypertension |
15.9% |
| Drug Use For Unknown Indication |
11.0% |
| Renal Transplant |
6.2% |
| Prophylaxis Against Transplant Rejection |
4.7% |
| Diabetes Mellitus |
3.9% |
| Type 2 Diabetes Mellitus |
3.6% |
| Acute Myocardial Infarction |
3.5% |
| Prophylaxis |
3.4% |
| Hyperlipidaemia |
3.3% |
| Multiple Myeloma |
2.8% |
| Atrial Fibrillation |
2.8% |
| Hypercholesterolaemia |
2.5% |
| Immunosuppression |
2.4% |
| Pain |
2.2% |
| Osteoporosis |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Depression |
2.1% |
| Insomnia |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
|
| Renal Failure Acute |
9.8% |
| Pyrexia |
8.1% |
| Syncope |
7.7% |
| Vomiting |
7.3% |
| Pneumonia |
6.4% |
| Pain In Extremity |
5.6% |
| Weight Decreased |
5.6% |
| Urinary Tract Infection |
5.1% |
| Myocardial Infarction |
4.7% |
| Pancreatitis Acute |
4.7% |
| Cerebrovascular Accident |
4.3% |
| Nausea |
4.3% |
| Sepsis |
4.3% |
| Hepatic Function Abnormal |
3.8% |
| Hyponatraemia |
3.8% |
| Atrial Fibrillation |
3.0% |
| Death |
3.0% |
| Transplant Rejection |
3.0% |
| Tremor |
3.0% |
| Cardiac Failure |
2.6% |
|
| Interacting |
| Hypertension |
20.0% |
| Bipolar I Disorder |
10.0% |
| Age-related Macular Degeneration |
6.7% |
| Heart Transplant |
6.7% |
| Lipids Increased |
6.7% |
| Prophylaxis |
6.7% |
| Acidosis |
3.3% |
| Anaemia |
3.3% |
| Cardiac Failure |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Dyslipidaemia |
3.3% |
| Helicobacter Gastritis |
3.3% |
| Hiccups |
3.3% |
| Hypercholesterolaemia |
3.3% |
| Hyperlipidaemia |
3.3% |
| Hyperparathyroidism Secondary |
3.3% |
| Hyperuricaemia |
3.3% |
| Immunosuppressant Drug Therapy |
3.3% |
| Renal Transplant |
3.3% |
|
| Visual Acuity Reduced |
22.2% |
| White Blood Cell Count Increased |
22.2% |
| Blood Creatine Phosphokinase Increased |
11.1% |
| Renal Failure Chronic |
11.1% |
| Rhabdomyolysis |
11.1% |
| Tachypnoea |
11.1% |
| Vomiting |
11.1% |
|
